Seaport Therapeutics, Inc. · NASDAQ:SPTX
PureTech Health plc reported a 31.20% stake in Seaport Therapeutics, Inc. (Schedule 13G)
Event Jun 30, 2026 · Filed Aug 14, 2026
PureTech Health plc reported a 31.20% stake in Seaport Therapeutics, Inc., 16,685,013 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G).
- Stake
- 31.20%
- Shares
- 16,685,013
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| PureTech Health plc | 31.20% | 16,685,013 |
| PureTech Health LLC | 31.20% | 16,685,013 |
| PureTech LYT, Inc. | 31.20% | 16,685,013 |
Source
Related
- Seaport Therapeutics, Inc.
- PureTech Health plc
- Seaport Therapeutics, Inc. shareholders
- Schedule 13G · Paul Steven M · Aug 5, 2026
- Schedule 13G · Zohar Daphne · Aug 5, 2026
- Form 4 · Hombach Robert J. · Jun 24, 2026
- Schedule 13G · Goldman Sachs Group Inc · May 11, 2026
- Schedule 13D · General Atlantic, L.P. · May 11, 2026